CCMI
PFE icon

Creative Capital Management Investments’s Pfizer PFE Stock Holding History

Creative Capital Management Investments’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$142K Buy
5,911
+297
+5% +$7.77K 0.03% 111
2026
Q1 		$158K Buy
5,614
+3,103
+124% +$82.6K 0.05% 71
2025
Q4 		$62.5K Hold
2,511
– – 0.02% 104
2025
Q3 		$64K Sell
2,511
-37
-1% -$913 0.02% 102
2025
Q2 		$61.8K Buy
2,548
+37
+1% +$863 0.02% 104
2025
Q1 		$63.6K Hold
2,511
– – 0.02% 96
2024
Q4 		$66.6K Hold
2,511
– – 0.03% 90
2024
Q3 		$72.7K Hold
2,511
– – 0.03% 84
2024
Q2 		$70.3K Sell
2,511
-477
-16% -$13.1K 0.03% 77
2024
Q1 		$82.9K Hold
2,988
– – 0.04% 68
2023
Q4 		$86K Buy
2,988
+692
+30% +$20.9K 0.05% 64
2023
Q3 		$76.2K Sell
2,296
-140
-6% -$4.95K 0.05% 70
2023
Q2 		$89.4K Hold
2,436
– – 0.06% 62
2023
Q1 		$99.4K Buy
2,436
+201
+9% +$8.68K 0.07% 67
2022
Q4 		$115K Buy
+2,235
New +$107K 0.1% 52

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Creative Capital Management Investments's PFE Position: Q2 2026 in Review

Creative Capital Management Investments increased its Pfizer (PFE) stake by 5.3% in Q2 2026, buying an estimated $7.77K and bringing the position to 5,911 shares worth $142K. The position accounts for 0.03% of the portfolio, ranked #111.

Creative Capital Management Investments first reported a position in PFE in Q4 2022 and has held it in 15 quarters since. The position peaked at $158K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Creative Capital Management Investments held 5,911 shares of Pfizer worth $142K as of Q2 2026.
  • Creative Capital Management Investments bought 297 Pfizer shares in Q2 2026, an estimated $7.77K.
  • Pfizer made up 0.03% of Creative Capital Management Investments's portfolio in Q2 2026, its #111 holding.
  • Creative Capital Management Investments first reported a position in Pfizer in Q4 2022 and has held it in 15 quarters since.
  • Creative Capital Management Investments's Pfizer position peaked at $158K in Q1 2026.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Creative Capital Management Investments's 13F filing for Q2 2026, filed 24 Jul 2026.